实用医学杂志 ›› 2021, Vol. 37 ›› Issue (9): 1122-1126.doi: 10.3969/j.issn.1006⁃5725.2021.09.005

• 基础研究 • 上一篇    下一篇

细胞外信号调节蛋白激酶1/2抑制药对慢性阻塞性肺疾病小鼠气道高分泌黏蛋白5ac的作用机制

覃英娇, 周向东, 钟有清, 王杰,刘峰1   

  1. 1 海南医学院第一附属医院呼吸内科(海口570102);2 急救与创伤研究教育部重点实验室(海口 571199); 3 中国医学科学院海岛急救医学创新单元(海口 571199)

  • 出版日期:2021-05-10 发布日期:2021-05-10
  • 通讯作者: 周向东 E⁃mail:zxd999@263.net
  • 基金资助:

    海南省医药卫生科研项目(编号:18A200141);海 南医学院第一附属医院青年培育基金(编号:HYFYPY201810); 海南医学院第一附属医院青年培育基金(编号:HYFYPY201718); 国家自然科学基金项目(编号:82011530049);海南省重点研发项 目(编号:ZDYF2020223)

The effects of ERK1/2 inhibitors on the airway hypersecretion of mucin 5ac(Muc5ac)in COPD mice

QIN Yingjiao,ZHOU Xiangdong,ZHONG Youqing,WANG Jie,LIU Feng.   

  1. Department of Respiratory Medicine,the First Affiliated Hospital of Hainan Medical College,Haikou 570102,China

  • Online:2021-05-10 Published:2021-05-10
  • Contact: ZHOU Xiang Dong E⁃mail:zxd999@263.net

摘要:

目的 探讨细胞外信号调节蛋白激酶 1/2(ERK1/2)抑制药对慢性阻塞性肺病(COPD)小鼠气道高分泌黏蛋白 5ac(muc5ac)的作用机制。方法 检测不同药物干预 7 d 后各组小鼠肺功能指标,白细胞介素 4(IL⁃4)、干扰素γ(IFN⁃γ)水平,HE 染色观察肺组织病理学变化,RT⁃qPCR 检测肺组织 muc5ac、ERK1/2 mRNA 表达水平,Western blot 检测肺组织 muc5ac、ERK1/2、p⁃ERK1/2 蛋白表达水平。结果 与模型组比较,抑制药组和西药组的低 0.3 s 用力呼气量(FEV0.3)、用力肺活量(FVC)、FEV0.3/ FVC、IL⁃4水平升高,IFN⁃γ水平、muc5ac mRNA表达量、muc5ac、p⁃ERK1/2蛋白表达量降低(P < 0.05),且肺组 织病理学变化改善。结论 ERK1/2抑制药通过抑制ERK1/2信号通路,下调muc5ac表达改善COPD症状。


关键词: 细胞外信号调节蛋白激酶1/2 , 慢性阻塞性肺病; , 小鼠; , 气道; , 黏蛋白

Abstract:

Objective To explore the mechanism of extracellular signal ⁃ regulated protein kinase 1/2 (ERK1/2)inhibitor U0126 on airway hypersecretion of mucin 5ac(muc5ac)protein in chronic obstructive pulmo⁃ nary disease(COPD)mice. Methods The pulmonary function indexes,interleukin 4(IL ⁃4)and interferon γ (IFN⁃γ)levels of each group of mice after 7 days of intervention with different drugs were detected.HE staining to observe the pathological changes of lung tissue. RT⁃qPCR was used to detect the expression levels of muc5ac and ERK1/2 mRNA in lung tissues. Western blotting was used to detect the expression levels of muc5ac,ERK1/2,and p⁃ERK1/2 proteins in lung tissue. Results Compared with the model group,the levels of FEV0.3,FVC,FEV0.3/ FVC and IL⁃4 in the inhibitory drug group and the western drug group were increased,whereas the levelsof IFN⁃γ, muc5acmRNA,and the protein expression levels of muc5ac and p⁃ERK1/2 were decreased(P < 0.05). The patho⁃ logical changes of lung tissue improved. Conclusion ERK1/2 inhibitors can reduce the expression of muc5ac by inhibiting the ERK1/2 signaling pathway and improve the symptoms of COPD.

Key words:

extracellular signal ? regulated protein kinase 1/2, chronic obstructive pulmonary disease, mouse, airway, mucin 5ac